Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitors.

Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitors.
复制标题

DOI:
10.1016/j.bmcl.2018.09.006
复制
发表时间:
2018-11-01
影响因子:
2.7
通讯作者:
Huang W
Huang W
中科院分区:
医学4区
文献类型:
--
作者:
Jiang JK;Huang X;Shamim K;Patel PR;Lee A;Wang AQ;Nguyen K;Tawa G;Cuny GD;Yu PB;Zheng W;Xu X;Sanderson P;Huang W

文献摘要

参考文献

被引文献

相似文献

The pyrazolo[1,5-a]pyrimidine LDN-193189 is a potent inhibitor of activin receptor-like kinase 2 (ALK2) but is nonselective for highly homologous ALK3 and shows only modest kinome selectivity. Herein, we describe the discovery of a novel series of potent and selective ALK2 inhibitors by replacing the quinolinyl with a 4-(sulfamoyl)naphthyl, yielding ALK2 inhibitors that exhibit not only excellent discrimination versus ALK3 but also high kinome selectivity. In addition, the optimized compound 23 demonstrates good ADME and in vivo pharmacokinetic properties.
DOI: 10.1007/s10456-014-9457-y
发表时间: 2015-04
期刊: ANGIOGENESIS
影响因子: 9.8
作者:
Kerr, Georgina;Sheldon, Helen;Chaikuad, Apirat;Alfano, Ivan;von Delft, Frank;Bullock, Alex N.;Harris, Adrian L.
通讯作者: Harris, Adrian L.
新型和选择性骨形态发生蛋白受体(BMP)抑制剂的合成和结构活性关系从吡唑洛斯[1.5-A]吡胺胺的嘧啶支架衍生而来:ML347的发现ML347作为ALK2对ALK2对ALK3对ALK3的选择性MLPCN探针。
DOI: 10.1016/j.bmcl.2013.03.113
发表时间: 2013-06-01
影响因子: 2.7
作者:
Engers, Darren W.;Frist, Audrey Y.;Lindsley, Craig W.;Hong, Charles C.;Hopkins, Corey R.
通讯作者: Hopkins, Corey R.
DOI: 10.1002/jbmr.2820
发表时间: 2016-09
期刊: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
影响因子: --
作者:
Chakkalakal SA;Uchibe K;Convente MR;Zhang D;Economides AN;Kaplan FS;Pacifici M;Iwamoto M;Shore EM
通讯作者: Shore EM
DOI: 10.1016/j.berh.2007.11.007
发表时间: 2008-03-01
影响因子: 5.2
作者:
Kaplan, Frederick S.;Le Merrer, Martine;Groppe, Jay
通讯作者: Groppe, Jay
DOI: 10.1021/jm501177w
发表时间: 2014-10-09
影响因子: 7.3
作者:
Mohedas AH;Wang Y;Sanvitale CE;Canning P;Choi S;Xing X;Bullock AN;Cuny GD;Yu PB
通讯作者: Yu PB